Press release
Generic Oncology Drugs Market will surpass US$ 23 Billion in 2021
Increased spending in cancer-related research and development by various governments and private and commercial organizations combined with investments in anti-cancer drugs are the two key factors anticipated to heighten the generic oncology drugs demand, through 2019, as indicated in a recent market analysis of generic oncology drugs, by Persistence Market Research (PMR). Expanding at a robust annual rate of over 6.1 percent, the global revenue through sales of generic oncology drugs will surpass US$ 23 Billion in 2021.
To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/25480
“PMR estimates that notable product pipeline for generic oncology drugs is expected to drive lucrative business opportunities. Moreover, with industry’s pipeline reaching a historic level of late-stage development, in 2017, almost 90% of the therapies being targeted treatments and clinical success rates going up to almost 73 percent, the market for generic oncology drugs is anticipated to grow, further expanding the pipeline cancer treatment”, explained a senior research analyst.
Small Molecule Generic Oncology Drugs Hold Big Opportunities in 2019
Expanding at a rather high CAGR of nearly 6.7 percent, small molecule generic oncology drugs, combing the efficacies of chemotherapy and immunotherapies could boost the ongoing cancer treatment modalities. Although, there has been a significant development in immunotherapy alone, small molecules are expected to exceed the efficacies of large molecules and dominate the cancer treatment landscape as medical exerts continually validate the positive outcomes by combing traditional cancer treatment with new immunotherapies, thereby providing increased benefits to cancer patients.
Request for Report Methodology @: https://www.persistencemarketresearch.com/methodology/25480
Although PMR analysis indicates a relatively lesser market share compared to market molecules, as a modality, small molecules are likely to benefit from their cross-membrane ability, reaching greater intracellular targets. Moreover, with a half-life of less than 24 hours, small molecules generic oncology drugs are more likely to achieve greater efficacy after a more convenient oral administration, thereby allowing researchers and clinicians to balance the side effect of combination trials through intermittent cancer treatment dosing.
“Research also indicates that more than a quarter of immune-oncology clinical trial use small as combination partners for checkpoint inhibitors, positioning itself as a unique compound class for superior immune-oncology treatments”, explains the analyst.
Potential Revenue Pockets in Emerging Economies
The generic oncology drugs landscape expanding at a robust annual growth rate of approximately 7.5 percent, APECJ along with is anticipated to present significant revenue generating avenues for drug manufacturing companies. Increased research and development on biological and targeted drug therapies, early expiration of patents, and increasing focus on personalized treatment medication are some major factors contributing towards future avenues for generic oncology cancer drugs market in APECJ. In Japan, on the other hand, stringent regulations involving drug discovery and development process could put a spanner in generic oncology drugs market growth.
“Increasing awareness and growing demand for early cancer diagnosis is expected to translate into homegrown generic oncology drugs, thereby presenting revenue generating opportunities for local drug manufacturers. Favorable reimbursement schemes for critical drugs and significant funding for drug manufacturing infrastructure by government and private organizations of emerging economies are some key factors supplementing to the sales of generic oncology drugs. In addition, contract manufacturing initiatives for biopharmaceuticals and small molecules could broaden the future scope of generic oncology drugs”, the senior analyst further explains.
View Report Table of Contents, Figures, and Tables
Product Pipeline Expansion to Remain the Core Forward Strategy
PMR, in its in-depth analysis of the generic oncology drugs market, presents an assessment of the competitive landscape, dominated by key companies including Novartis AG, Pfizer Inc, GlaxoSmithKline Plc, Celgene Corp., Mylan N.V., Merck & Co., Inc, NATCO Pharma Limited, and Aurobindo Pharma.
Get access to full summary @: https://www.persistencemarketresearch.com/market-research/generic-oncology-drugs-market.asp
Key insights in this segment, includes:
Novartic AG, has applied channel integration strategies such as e-commerce along with the mobile app to drive sales at retail locations. Moreover, the company recently gave global rights of AKT inhibitors afuresertib and uprosertib — to the Shanghai-based company Laekna. In addition, Novartis AG received CE mark for gene-modifying therapy for blood cancer Kymriah.
Pfizer Inc., on the other hand, is focused on 39 therapies in R&D pipeline for oncology and bio similar to strengthen the core areas of the product portfolio. In 2017, Pfizer’s Glasdegib in patients with previously untreated acute myeloid leukemia received U.S FDA priority review. In the same year, company’s XTANDI (enzalutamide) too received FDA approval.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Generic Oncology Drugs Market will surpass US$ 23 Billion in 2021 here
News-ID: 1464671 • Views: …
More Releases from Persistence Market Research
North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
Overview of the North America Wiring Devices Market
The North America wiring devices market is poised for steady growth over the forecast period, with its size estimated at US$ 18.96 billion in 2024, projected to reach US$ 26.46 billion by 2031, reflecting a CAGR of 4.9%. The market is witnessing substantial expansion due to increasing urbanization, a rising number of residential and commercial construction projects, and the adoption of energy-efficient and…
Global Forged Automotive Components Market Poised for Steady Growth, Projected t …
The global forged automotive components market is on a robust growth trajectory, currently valued at approximately US$ 50.3 billion in 2025 and forecasted to expand to US$ 70.7 billion by the end of 2032. This growth represents a compound annual growth rate (CAGR) of 5.0% over the coming decade, driven by increasing automotive production, technological advancements, and evolving consumer preferences toward durable, high-performance vehicle parts.
Forged automotive components are critical to…
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ …
The global electric cargo bike market is set to experience substantial growth over the coming decade, with Persistence Market Research (PMR) forecasting a compound annual growth rate (CAGR) of 11.9% from 2023 through 2032. Valued at approximately US$ 800 million in 2021, the market is expected to surge to a projected valuation of US$ 2.14 billion by the end of 2032. Notably, electric cargo bikes accounted for 66.2% of the…
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Drive …
The global bicycle bearings market is poised for significant expansion over the forecast period of 2025 to 2032, according to the latest report released by Persistence Market Research. Valued at approximately US$ 5.99 billion in 2024, the market is projected to reach US$ 6.35 billion by 2025 and further escalate to nearly US$ 9.86 billion by 2032. This growth trajectory reflects a compound annual growth rate (CAGR) of 6.5%, underscoring…
More Releases for PMR
Starch Derivatives Market Outlook by 2021 : PMR
Starch derivatives, also known as modified starch, are prepared by enzymatically, physically or chemically treating native starch to alter its properties. Starch derivatives are used in a number of industries for various functions. They are used as thickeners and stabilizers in the food and beverage industry, as a tablet binder in the pharmaceutical industry, as an emulsifier in cosmetics, and fiber additive in the animal feed. Some of the other…
Yeast Ingredients Market Outlook by 2021 : PMR
Yeasts are chemoorganotrophs, as they use organic compounds to source energy and do not require sunlight for growth or survival. Yeasts are usually unicellular; although some species may be multi-cellular. The size of yeast depends on the species. Yeasts usually measure 3 to 4 µm in diameter. However, certain yeasts reach up to 40 µm in diameter. Yeasts reproduce asexually through mitosis (a process, in which, the chromosomes in a…
Confectionery Market Outlook by 2021 : PMR
The confectionery market is one of the growing sectors globally . Usually, confections are low in nutrients and high in calorie. Sugar-free confections are gaining popularity in the recent years due to factors such as increasing obesity rate, increasing number of diabetic patients, increasing nutritional and health concerns, and changing lifestyle. The confectionery market can be primarily divided into two broad categories: sugar confectionery and bakers’ confectionery . Sugar confectionery…
Cereal Bars Market Outlook by 2021 : PMR
A cereal bar is made up of nuts, oats, sugar, dry fruits, flour, honey, wheat, corn, and puffed rice. Cereal bars have always been perceived as on-the-go breakfast snack items that are healthier alternatives of chocolate and other snacks. Cereal bars are high in fiber and protein and low in carbohydrates, vitamins, minerals, sodium, and antioxidants. They come in various flavors such as chocolate, peanut butter, banana, caramel, banana, honey,…
Functional Flours Market Share by 2026 : PMR
The natural flours used for specialty applications in the food industry and undergoes different treatment process to improve their properties are called functional flours. The various properties of functional flours include cold binding capacity, thermal binding capacity, machinability, dough hydration etc. The functional flours are classified as waxy, multi-benefit, instant and granulated type depending on its features. They undergo different physical and nutritional treatment to enhance its features. In dietary…
Global Ceilings Market Snapshot by 2020 : PMR
Ceiling is overhead interior portion within the room which covers the upper portion of the room. Main purpose of ceiling is to achieve the desired height of the roof in the room. Ceilings are frequently decorated with attractive paintings, mosaic tiles and other different designs. Major advantage of decorated ceiling is that it gets protected from damage by fingers and dust. There are certain ceilings which are fire resistance; dropping…
